PRVRX
Price
$13.61
Change
-$0.05 (-0.37%)
Updated
Oct 7 closing price
Net Assets
249.82M
RMFCX
Price
$62.10
Change
-$0.10 (-0.16%)
Updated
Oct 7 closing price
Net Assets
112.6B
Interact to see
Advertisement

PRVRX vs RMFCX

Header iconPRVRX vs RMFCX Comparison
Open Charts PRVRX vs RMFCXBanner chart's image
PGIM Quant Solutions Large-Cap Val R
Price$13.61
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets249.82M
American Funds American Mutual R3
Price$62.10
Change-$0.10 (-0.16%)
VolumeN/A
Net Assets112.6B
PRVRX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
PRVRX vs. RMFCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRVRX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 113B vs. PRVRX (250M). PRVRX pays higher dividends than RMFCX: PRVRX (2.41) vs RMFCX (1.20). PRVRX was incepted earlier than RMFCX: PRVRX (10 years) vs RMFCX (23 years). PRVRX (1.75) is less costly to investors than RMFCX (0.91). PRVRX is a more actively managed with annual turnover of: 96.00 vs. RMFCX (31.00). PRVRX has a lower initial minimum investment than RMFCX: PRVRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 8.11 vs. PRVRX (-2.50). RMFCX return over 5 years is better than : 59.28 vs. PRVRX (41.14).
PRVRXRMFCXPRVRX / RMFCX
Total Expense Ratio1.320.91145%
Annual Report Gross Expense Ratio1.750.91192%
Fund Existence10 years23 years-
Gain YTD11.96714.77981%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets250M113B0%
Annual Yield % from dividends2.411.20200%
Returns for 1 year-2.508.11-31%
Returns for 3 years17.9043.6141%
Returns for 5 years41.1459.2869%
Returns for 10 years11.2293.9012%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO8.341.87
+28.90%
Lexeo Therapeutics
FRMEP25.74-0.06
-0.23%
First Merchants Corp
VMI397.23-3.13
-0.78%
Valmont Industries
UFPT196.98-4.95
-2.45%
UFP Technologies
KPTI5.77-0.39
-6.33%
Karyopharm Therapeutics Inc.